Seminars in Oncology
Volume 31, Issue 5 , Pages 693-701, October 2004

Management of brain metastases

  • Kristin A. Bradley

      Affiliations

    • Department of Human Oncology, University of Wisconsin, Madison, WI, USA.
    • ,
  • Minesh P. Mehta

      Affiliations

    • Department of Human Oncology, University of Wisconsin, Madison, WI, USA.
    • M.M. has received research funding or has served on the advisory board of or has participated in lectureship programs sponsored by one or more of the following: Schering-Plough, Pharmacyclics, Eli Lilly, GlaxoSmithKline, General Electric, TomoTherapy, Inc., Varian, ProCertus BioPharm, Inc. UltraVisual, Gammex RMI, Peregrine, AstraZeneca, Bristol-Myers Squibb, and ADAC.
    • Corresponding Author InformationAddress reprint requests to Minesh P. Mehta, MD, University of Wisconsin, Department of Human Oncology, 600 Highland Ave, K4/310-3684, Madison, WI 53792.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

PII: S0093-7754(04)00334-3

doi:10.1053/j.seminoncol.2004.07.012

Seminars in Oncology
Volume 31, Issue 5 , Pages 693-701, October 2004

Article Tools